Nuclear receptors in bile acid metabolism

Drug Metabolism Reviews

Volumn 45, Issue 1, 2013, Pages 145-155

  Li, Tiangang ^a   Chiang, John Y L ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Bile acid synthesis; Cholestasis; Drug metabolism; Nuclear receptors

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID CONJUGATE; BILE SALT EXPORT PUMP; BINDING PROTEIN; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 3A; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; FIBROBLAST GROWTH FACTOR 19; GLUCURONOSYLTRANSFERASE 1A1; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; NA+ DEPENDENT TAUROCHOLATE COTRANSPORT PEPTIDE; OBETICHOLIC ACID; ORGANIC SOLUTE TRANSPORTER ALPHA; ORGANIC SOLUTE TRANSPORTER BETA; PREGNANE X RECEPTOR; RIFAMPICIN; SMALL HETERODIMER PARTNER; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

BILE ACID METABOLISM; BILE ACID SYNTHESIS; DIABETES MELLITUS; DIGESTIVE SYSTEM; DRUG ABSORPTION; DRUG CONJUGATION; DRUG METABOLISM; DRUG OXIDATION; DRUG TRANSPORT; ENERGY METABOLISM; ENTEROHEPATIC CIRCULATION; GENE TARGETING; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; LIPID METABOLISM; LIVER PROTECTION; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; OBESITY; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; HUMANS; METABOLIC DETOXICATION, DRUG; RECEPTORS, CYTOPLASMIC AND NUCLEAR; XENOBIOTICS;

EID: 84872741573     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2012.740048     Document Type: Review

References (95)

1. Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., Suchy, F. J. (2001). Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276: 28857-28865.
2. Arrese, M., Trauner, M., Sacchiero, R. J., Crossman, M. W., Shneider, B. L. (1998). Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter. Hepatology 28: 1081-1087. (Pubitemid 28450270)
3. Beilke, L. D., Aleksunes, L. M., Holland, R. D., Besselsen, D. G., Beger, R. D., Klaassen, C. D., et al. (2009a). Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice. Drug Metab Dispos 37: 1035-1045.
4. Beilke, L. D., Aleksunes, L. M., Olson, E. R., Besselsen, D. G., Klaassen, C. D., Dvorak, K., et al. (2009b). Decreased apoptosis during CARmediated hepatoprotection against lithocholic acid-induced liver injury in mice. Toxicol Lett 188: 38-44.
5. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., et al. (2000). Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775. (Pubitemid 32004809)
6. Bhalla, S., Ozalp, C., Fang, S., Xiang, L., Kemper, J. K. (2004). Ligandactivated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem 279: 45139-45147. (Pubitemid 39430929)
7. Bhatnagar, S., Damron, H. A., Hillgartner, F. B. (2009). Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 284: 10023-10033.
8. Boyer, J. L. (1980). New concepts of mechanisms of hepatocyte bile formation. Physiol Rev 60: 303-326. (Pubitemid 10091891)
9. Boyer, J. L., Trauner, M., Mennone, A., Soroka, C. J., Cai, S. Y., Moustafa, T., et al. (2006). Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 290: G1124-G1130. (Pubitemid 43788293)
10. Chai, J., Luo, D., Wu, X., Wang, H., He, Y., Li, Q., et al. (2011). Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis. J Gastrointest Surg 15: 996-1004.
11. Chatterjee, B., Echchgadda, I., Song, C. S. (2005). Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. Methods Enzymol 400: 165-191. (Pubitemid 43052421)
12. Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., et al. (2003). Liver receptor homologue-1 mediates species-and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem 278: 19909-19916. (Pubitemid 36799181)
13. Chen, X., Chen, F., Liu, S., Glaeser, H., Dawson, P. A., Hofmann, A. F., et al. (2006). Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor. Mol Pharmacol 69: 1913-1923. (Pubitemid 43894308)
14. Chiang, J. Y. (1998). Regulation of bile acid synthesis. Front Biosci 3: D176-D193.
15. Chiang, J. Y. (2009). Bile acids: regulation of synthesis. J Lipid Res 50: 1955-1966.
16. Childs, S., Yeh, R. L., Georges, E., Ling, V. (1995). Identification of a sister gene to P-glycoprotein. Cancer Res 55: 2029-2034.
17. Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., et al. (2006). Identification of a hormonal basis for gallbladder filling. Nat Med 12: 1253-1255. (Pubitemid 44706926)
18. Claudel, T., Zollner, G., Wagner, M., Trauner, M. (2011). Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochim Biophys Acta 1812: 867-878.
19. Cui, Y. J., Aleksunes, L. M., Tanaka, Y., Goedken, M. J., Klaassen, C. D. (2009). Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci 110: 47-60.
20. Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., et al. (2005). The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 280: 6960-6968. (Pubitemid 40341252)
21. Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., et al. (2001). The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121: 140-147. (Pubitemid 32591524)
22. Drocourt, L., Ourlin, J. C., Pascussi, J. M., Maurel, P., Vilarem, M. J. (2002). Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277: 25125-25132. (Pubitemid 34951818)
23. Eloranta, J. J., Kullak-Ublick, G. A. (2005). Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433: 397-412. (Pubitemid 39592794)
24. Fiorucci, S., Cipriani, S., Baldelli, F., Mencarelli, A. (2010). Bile acidactivated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 49: 171-185.
25. Gao, J., Xie, W. (2012). Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci 33: 552-558.
26. Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., et al. (2000). A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6: 517-526.
27. Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., et al. (1999). Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid x receptor/9-cis-retinoic acid receptor heterodimer. J Biol Chem 274: 29749-29754.
28. Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Jr., Kliewer, S. A., et al. (2003). Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278: 45062-45071. (Pubitemid 37432638)
29. Han, S., Chiang, J. Y. (2009). Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos 37: 469-478.
30. Han, S., Li, T., Ellis, E., Strom, S., Chiang, J. Y. (2010). A novel bile acidactivated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol 24: 1151-1164.
31. He, J., Nishida, S., Xu, M., Makishima, M., Xie, W. (2011). PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 140: 2095-2106.
32. Hirohashi, T., Suzuki, H., Takikawa, H., Sugiyama, Y. (2000). ATPdependent transport of bile salts by rat multidrug resistanceassociated protein 3 (Mrp3). J Biol Chem 275: 2905-2910. (Pubitemid 30082066)
33. Hofmann, A. F. (2002). Rifampicin and treatment of cholestatic pruritus. Gut 51: 756-757.
34. Hofmann, A. F. (2004). Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev 36: 703-722. (Pubitemid 39453070)
35. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2: 217-225.
36. Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., et al. (2002). Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908-2915. (Pubitemid 34953324)
37. Kim, I., Ahn, S. H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., et al. (2007). Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48: 2664-2672. (Pubitemid 350272851)
38. Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., et al. (2011). FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331: 1621-1624.
39. Kliewer, S. A., Willson, T. M. (2002). Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43: 359-364. (Pubitemid 34252265)
40. Kok, T., Hulzebos, C. V., Wolters, H., Havinga, R., Agellon, L. B., Stellaard, F., et al. (2003). Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 278: 41930-41937. (Pubitemid 37310455)
41. Kong, B., Wang, L., Chiang, J. Y., Zhang, Y., Klaassen, C. D., Guo, G. L. (2012). Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56: 1034-1043.
42. Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B., Meier, P. J. (2000). Hepatic transport of bile salts. Semin Liver Dis 20: 273-292.
43. Langheim, S., Yu, L., von Bergmann, K., Lutjohann, D., Xu, F., Hobbs, H. H., et al. (2005). ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J Lipid Res 46: 1732-1738. (Pubitemid 41099340)
44. Lee, H., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., Edwards, P. A. (2006). FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res 47: 201-214. (Pubitemid 43107463)
45. Lee, M. H., Lu, K., Hazard, S., Yu, H., Shulenin, S., Hidaka, H., et al. (2001). Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83. (Pubitemid 32044523)
46. Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., Staels, B. (2009). Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147-191.
47. Li, T., Chiang, J. Y. (2005). Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 288: G74-G84. (Pubitemid 39665222)
48. Lundasen, T., Galman, C., Angelin, B., Rudling, M. (2006). Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 260: 530-536. (Pubitemid 44772372)
49. Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., et al. (2002). Vitamin D receptor as an intestinal bile acid sensor. Science 296: 1313-1316. (Pubitemid 34522785)
50. Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., et al. (1999). Identification of a nuclear receptor for bile acids. Science 284: 1362-1365. (Pubitemid 29289663)
51. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
52. Marschall, H. U., Wagner, M., Bodin, K., Zollner, G., Fickert, P., Gumhold, J., et al. (2006). Fxr mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 47: 582-592. (Pubitemid 43345599)
53. Mason, J. I., Boyd, G. S. (1978). The suppressive effect of the catatoxic steroid, pregnenolone-16alpha-carbonitrile, on liver microsomal cholesterol-7alpha-hydroxlyase. Steroids 31: 849-854. (Pubitemid 9119861)
54. McCarthy, T. C., Li, X., Sinal, C. J. (2005). Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280: 23232-23242. (Pubitemid 40853235)
55. Mencarelli, A., Fiorucci, S. (2010). FXR an emerging therapeutic target for the treatment of atherosclerosis. J Cell Mol Med 14: 79-92.
56. Mennone, A., Soroka, C. J., Cai, S. Y., Harry, K., Adachi, M., Hagey, L., et al. (2006). Mrp4-/-mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 43: 1013-1021. (Pubitemid 43724626)
57. Miao, J., Fang, S., Bae, Y., Kemper, J. K. (2006). Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J Biol Chem 281: 14537-14546. (Pubitemid 43855156)
58. Miyata, M., Sakaida, Y., Matsuzawa, H., Yoshinari, K., Yamazoe, Y. (2011). Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice. Biol Pharm Bull 34: 1885-1889.
59. Modica, S., Bellafante, E., Moschetta, A. (2009). Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio. Front Biosci 14: 4719-4745.
60. Nagpal, S., Na, S., Rathnachalam, R. (2005). Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687. (Pubitemid 41127276)
61. Neimark, E., Chen, F., Li, X., Shneider, B. L. (2004). Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 40: 149-156. (Pubitemid 38877576)
62. Nishida, S., Ozeki, J., Makishima, M. (2009). Modulation of bile acid metabolism by 1alpha-hydroxyvitamin D3 administration in mice. Drug Metab Dispos 37: 2037-2044.
63. Ogura, M., Nishida, S., Ishizawa, M., Sakurai, K., Shimizu, M., Matsuo, S., et al. (2009). Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice. J Pharmacol Exp Ther 328: 564-570.
64. Pandak, W. M., Li, Y. C., Chiang, J. Y., Studer, E. J., Gurley, E. C., Heuman, D. M., et al. (1991). Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted rat. J Biol Chem 266: 3416-3421. (Pubitemid 21909229)
65. Pellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., et al. (2004). Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. J Med Chem 47: 4559-4569. (Pubitemid 39096842)
66. Porez, G., Prawitt, J., Gross, B., Staels, B. (2012). Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease: Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases. J Lipid Res 53: 1723-1737.
67. Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., et al. (2011). FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metab 13: 729-738.
68. Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., Dawson, P. A. (2008). The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci USA 105: 3891-3896. (Pubitemid 351723495)
69. Rizzo, G., Renga, B., Mencarelli, A., Pellicciari, R., Fiorucci, S. (2005). Role of FXR in regulating bile acid homeostasis and relevance for human diseases. Curr Drug Targets Immune Endocr Metabol Disord 5: 289-303. (Pubitemid 41131707)
70. Russell, D. W., Setchell, K. D. (1992). Bile acid biosynthesis. Biochemistry 31: 4737-4749.
71. Saini, S. P., Sonoda, J., Xu, L., Toma, D., Uppal, H., Mu, Y., et al. (2004). A novel constitutive androstane receptor-mediated and CYP3Aindependent pathway of bile acid detoxification. Mol Pharmacol 65: 292-300. (Pubitemid 38134256)
72. Schaap, F. G., van der Gaag, N. A., Gouma, D. J., Jansen, P. L. (2009). High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49: 1228-1235.
73. Schmidt, D. R., Holmstrom, S. R., Fon Tacer, K., Bookout, A. L., Kliewer, S. A. & Mangelsdorf, D. J. (2010). Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem 285: 14486-14494.
74. Schmiedlin-Ren, P., Thummel, K. E., Fisher, J. M., Paine, M. F., Watkins, P. B. (2001). Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor. Drug Metab Dispos 29: 1446-1453. (Pubitemid 33000691)
75. Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., Gonzalez, F. J. (2000). Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744.
76. Sinha, J., Chen, F., Miloh, T., Burns, R. C., Yu, Z. & Shneider, B. L. (2008). Beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol 295: G996-G1003.
77. Smit, J. J., Schinkel, A. H., Oude Elferink, R. P., Groen, A. K., Wagenaar, E., van Deemter, L., et al. (1993). Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462. (Pubitemid 23335071)
78. Song, K. H., Li, T., Owsley, E., Strom, S., Chiang, J. Y. (2009). Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49: 297-305.
79. Stahlberg, D. (1995). Effects of pregnenolone-16 alpha-carbonitrile on the metabolism of cholesterol in rat liver microsomes. Lipids 30: 361-364.
80. Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N., Wolf, C. R. (2006). PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 38: 515-597. (Pubitemid 44167200)
81. Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., et al. (2001). The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98: 3369-3374. (Pubitemid 32220852)
82. Stedman, C. A., Liddle, C., Coulter, S. A., Sonoda, J., Alvarez, J. G., et al. (2005). Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci USA 102: 2063-2068. (Pubitemid 40262012)
83. Strautnieks, S. S., Kagalwalla, A. F., Tanner, M. S., Knisely, A. S., Bull, L., Freimer, N., et al. (1997). Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 61: 630-633. (Pubitemid 27418404)
84. Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., Senn, T., Lin, Y., et al. (2001). Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol 60: 1399-1406. (Pubitemid 33144911)
85. Trauner, M., Boyer, J. L. (2003). Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83: 633-671. (Pubitemid 36378680)
86. Wada, T., Gao, J., Xie, W. (2009). PXR and CAR in energy metabolism. Trends Endocrinol Metab 20: 273-279.
87. Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., et al. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125: 825-838. (Pubitemid 37070700)
88. Wagner, M., Zollner, G., Trauner, M. (2011). Nuclear receptors in liver disease. Hepatology 53: 1023-1034.
89. Wang, H., Venkatesh, M., Li, H., Goetz, R., Mukherjee, S., Biswas, A., et al. (2011). Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest 121: 3220-3232.
90. Wang, L., Lee, Y. K., Bundman, D., Han, Y., Thevananther, S., Kim, C. S., et al. (2002). Redundant pathways for negative feedback regulation of bile Acid production. Dev Cell 2: 721-731. (Pubitemid 34650069)
91. Wistuba, W., Gnewuch, C., Liebisch, G., Schmitz, G., Langmann, T. (2007). Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR. World J Gastroenterol 13: 4230-4235. (Pubitemid 47377162)
92. Zelcer, N., Reid, G., Wielinga, P., Kuil, A., van der Heijden, I., Schuetz, J. D., et al. (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 371: 361-367. (Pubitemid 36547618)
93. Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., et al. (2007). Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 27: 920-929. (Pubitemid 47261945)
94. Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., et al. (2006). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 290: G923-G932.
95. Zweers, S. J., Booij, K. A., Komuta, M., Roskams, T., Gouma, D. J., Jansen, P. L., et al. (2012). The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 55: 575-583.